Introducing the Premier Home Test Kit for genetic risk assessment:
Determine your personal likelihood of developing ovarian cancer over the next 5 years & lifetime with a combined clinical & genetic risk assessment test derived from up to 200 genetic markers, including all racial variables for disease.
All with a simple, easy-to-use cheek swab from the comfort of your home.
Original price was: $299.00.$149.00Current price is: $149.00.
You Will Receive a
Clear, Easy To Understand Report
And a Personal, one-on-one appointment with
GeneType’s Genetic Counselors
No. This risk assessment does not test for hereditary breast and ovarian cancer (HBOC), or any other hereditary cancer syndrome. geneType is a risk assessment for asymptomatic women in the general population who are either ineligible for HBOC testing, or who have come back as negative carriers following HBOC testing.
GeneType for Ovarian Cancer combines several of risk factor, such as age, family history, and your DNA markers, into one comprehensive risk assessment.
GeneType for Ovarian Cancer is for women aged 40 years or older.
No. This test is not applicable to women who have a personal history of ovarian cancer or who have already been shown to have an HBOC mutation, for example in the BRCA1 or BRCA2 gene, or a diagnosis of a genetic syndrome that may be associated with elevated risk of ovarian cancer.
YOUR OVARIAN CANCER RISK
IS MORE THAN YOUR FAMILY HISTORY
Ovarian cancer often doesn’t lead to noticeable symptoms until late in the disease.
Take charge. Know your risk. Learn if you have more options to reduce your risk.
